Osteosarcoma is a rare tumor diagnosed at any age; however younger age is a common risk
factor. In addition, multiple factors are believed to contribute to higher rates of osteosarcoma …

Long-term outcome for patients with high-grade osteosarcoma has improved with the
addition of systemic chemotherapy, but subsequent progress has been less marked …

Osteosarcoma (OSA) is a rare cancer in people. However OSA incidence rates in dogs are
27 times higher than in people. Prognosis in both species is relatively poor, with 5 year OSA …

Osteosarcoma is the most common malignant bone tumor, currently treated with pre-and
postoperative chemotherapy in association with the surgical removal of the tumor. About 15 …

Nanoceria or cerium oxide nanoparticles characterised by the co-existing of Ce3+ and Ce4+
that allows self-regenerative, redox-responsive dual-catalytic activities, have attracted …

Osteosarcoma is the most common primary malignancy of bone. It arises in bone during
periods of rapid growth and primarily affects adolescents and young adults. The 5‐year …

Providing comprehensive coverage of the biological activities and industrial applications of
Chitin, Chitosan, oligosaccharides, and their derivatives, this book presents a balance of …

Abstract Purpose: Recombinant Listeria vaccines induce tumor-specific T-cell responses
that eliminate established tumors and prevent metastatic disease in murine cancer models …

Piwi-interacting RNAs (piRNAs) are a novel type of small noncoding RNAs, which are 26–30
nt in length and bind to Piwi proteins. These short RNAs were originally discovered in …

Osteosarcoma (OSA) is the most common primary bone tumour in dogs. The appendicular
locations are most frequently involved and large to giant breed dogs are commonly affected …